Skip to main navigation Skip to search Skip to main content

A Long-term Follow-up of Study 64041575RSV2004 to Evaluate the Impact of Lumicitabine (JNJ-64041575) on the Incidence of Asthma and/or Wheezing in Infants and Children with a History of Respiratory Syncytial Virus Infection

Project: Research

Project Details

StatusFinished
Effective start/end date02/13/18 → 10/30/21

Funding

  • Janssen Research and Development LLC: $9,296.00